BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 928338)

  • 1. [6-years' experience with the clinical use of the hemostatic preparation, PPSB].
    Koniukhov SG; Saltykova ZA; Tarasova LN
    Probl Gematol Pereliv Krovi; 1977 Aug; 22(8):37-40. PubMed ID: 928338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with the PPSB fraction in surgery].
    Frick U
    Zentralbl Chir; 1972 Feb; 97(5):150-3. PubMed ID: 5020589
    [No Abstract]   [Full Text] [Related]  

  • 3. Activated prothrombin concentrate for patients with factor VIII inhibitors.
    Kurczynski EM; Penner JA
    N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
    [No Abstract]   [Full Text] [Related]  

  • 4. Human prothrombin complex.
    N Engl J Med; 1965 Sep; 273(13):715-6. PubMed ID: 5827038
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: Factor VIII inhibitors.
    Deykin D
    N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
    [No Abstract]   [Full Text] [Related]  

  • 6. Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding.
    Quinlan DJ; Eikelboom JW; Weitz JI
    Circulation; 2013 Sep; 128(11):1179-81. PubMed ID: 23935012
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of hemophilia B with a new clotting-factor concentrate.
    Hoag MS; Johnson FF; Robinson JA; Aggeler PM
    N Engl J Med; 1969 Mar; 280(11):581-6. PubMed ID: 5764825
    [No Abstract]   [Full Text] [Related]  

  • 8. ACP Journal Club. 4F-PCC was noninferior to plasma in patients with acute major bleeding who needed urgent VKA reversal.
    Lang E
    Ann Intern Med; 2014 Apr; 160(8):JC6. PubMed ID: 24733223
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reflections on the use of PPSB fraction (Prothrombin-proconvertin-Stuart factor-antihemophilic factor B)].
    Malinvaud G
    Transfusion (Paris); 1966; 9(3):245-54. PubMed ID: 5969560
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).
    O'Leary DS; Ruymann FB; Conrad ME
    J Lab Clin Med; 1971 Jan; 77(1):23-32. PubMed ID: 5540427
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparation and clinical use of P.P.S.B. (factors II, VII, X and IX concentrate).
    Soulier JP; Ménaché D; Steinbuch M; Blatrix C; Josso F
    Thromb Diath Haemorrh Suppl; 1968; 35():61-72. PubMed ID: 5761074
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use and abuse of prothrombin-complex concentrates].
    Veltkamp JJ; Siewertz van Reesema DR; Boekhout-Mussert MJ
    Ned Tijdschr Geneeskd; 1978 May; 122(21):766-7. PubMed ID: 652091
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical use of human prothrombin complexes.
    Tullis JL; Melin M; Jurigian P
    N Engl J Med; 1965 Sep; 273(13):667-74. PubMed ID: 5827030
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of intraventricular haemorrhage in babies receiving artificial ventilation.
    Thomas DB; Burnard ED
    Med J Aust; 1973 May; 1(19):933-6. PubMed ID: 4577114
    [No Abstract]   [Full Text] [Related]  

  • 15. The preparation for therapeutic use of a concentrate of factor IX containing also factors II, VII and X.
    Bidwell E; Booth JM; Dike GW; Denson KW
    Br J Haematol; 1967 Jul; 13(4):568-79. PubMed ID: 6029956
    [No Abstract]   [Full Text] [Related]  

  • 16. [Administration of a new prothrombin complex concentrate in patients treated with anticoagulants and in patients with liver diseases].
    Fischer M; Falkensammer C; Gauss P; Korp W; Kubiena K; Neubert J; Schnack H; Weissmann A
    Med Welt; 1973 Nov; 24(48):1899-902. PubMed ID: 4774863
    [No Abstract]   [Full Text] [Related]  

  • 17. [Substitution therapy with prothrombin complex concentrates in acquired coagulation disorders].
    Fischer M
    Wien Klin Wochenschr; 1983 Feb; 95(3):82-5. PubMed ID: 6858171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of PPSB fraction in the treatment of hemophilia A with antibodies against factor VIII].
    Hrubisková K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(4):672-82. PubMed ID: 6162735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of new hemostatic drug in dental practice].
    Saltykova ZA; Tarasova LN
    Stomatologiia (Mosk); 1974; 53(1):85-6. PubMed ID: 4547105
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant blood clotting proteins for hemophilia therapy.
    Limentani SA; Roth DA; Furie BC; Furie B
    Semin Thromb Hemost; 1993; 19(1):62-72. PubMed ID: 8456325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.